Invesaro

Stocks Health care CDNA

NASDAQ · Health care

CareDx, Inc. (CDNA)

CareDx, Inc. brought in $458.1M of revenue over the twelve months to June 30, 2026, up 34.4% from a year earlier. Net income was $111M, a net margin of 24.2%. At June 30, 2026 it held $373.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.

Revenue (last 12 months)
$458.1M
+34.4% year on year
Net margin
24.2%

What CareDx, Inc. does

CareDx, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker CDNA.

Revenue and profit by year

Revenue
FY18: $76.6M $76.6M FY18FY19: $127.1M $127.1M FY19FY20: $192.2M $192.2M FY20FY21: $296.4M $296.4M FY21FY22: $321.8M $321.8M FY22FY23: $280.3M $280.3M FY23FY24: $333.8M $333.8M FY24FY25: $379.8M $379.8M FY25
Net income
FY18: -$46.8M -$46.8M FY18FY19: -$22M -$22M FY19FY20: -$18.7M -$18.7M FY20FY21: -$30.7M -$30.7M FY21FY22: -$76.6M -$76.6M FY22FY23: -$190.3M -$190.3M FY23FY24: $52.5M $52.5M FY24FY25: -$21.4M -$21.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$379.8M-$30.8M-$21.4M-$0.40n/a
2024$333.8M$40.8M$52.5M$0.93n/a
2023$280.3M-$203.4M-$190.3M-$3.54n/a
2022$321.8M-$77.2M-$76.6M-$1.44n/a
2021$296.4M-$29.7M-$30.7M-$0.59n/a
2020$192.2M-$22.5M-$18.7M-$0.40n/a

Latest SEC filings

What CareDx, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 16, 2026
    Acquisition or sale completed 8-K/A
  2. August 14, 2026
    Passive stake changed SCHEDULE 13G/A
  3. August 7, 2026
    Passive stake changed SCHEDULE 13G/A
  4. August 7, 2026
    Passive stake (5% or more) SCHEDULE 13G
  5. July 30, 2026
    Employee stock plan registration S-8
  6. July 30, 2026
    Quarterly report 10-Q · period to June 30, 2026
  7. July 30, 2026
    Quarterly results 8-K
  8. July 27, 2026
    Passive stake changed SCHEDULE 13G/A
  9. July 7, 2026
    Acquisition or sale completed 8-K
  10. June 15, 2026
    Executive or director change 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 15, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about CDNA

What does CareDx, Inc. do?

CareDx, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker CDNA.

Is CareDx, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $111M on revenue of $458.1M, a net margin of 24.2%.

How much revenue does CareDx, Inc. make?

Over the twelve months to June 30, 2026 CareDx, Inc. reported revenue of $458.1M. That is 34.4% more than a year earlier.

When did CareDx, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the acquisition or sale completed from September 16, 2026.

Similar companies

LH
Labcorp Holdings Inc.
DGX
Quest Diagnostics Inc
FTRE
Fortrea Holdings Inc.
NTRA
Natera, Inc.
RDNT
RadNet, Inc.
GH
Guardant Health, Inc.

Follow CDNA

Get an email when CareDx, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CDNA: get an email when it files

Where the numbers come from

Financial figures are the values CareDx, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.